We have had the privilege of partnering with GxP Cellators for the past five years, during which time they have provided invaluable oversight of our quality and regulatory programs. Their expertise was instrumental in setting up our parent manufacturing site, which currently meets FDA and Health Canada-GMP standards. We are pleased to report that GxP Cellators is now assisting us in establishing a second manufacturing site that will generate GMP-grade CBD Isolates for clinical use. This is an exciting development for our research, and we are grateful for the continued support of GxP Cellators in this endeavour.